New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18
Oncology January 30,2024
Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18
Oncology January 30,2024
Research predicts cancer patients' response to chemotherapy agent cisplatin

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e
Oncology January 30,2024
Research predicts cancer patients' response to chemotherapy agent cisplatin

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e
Oncology January 30,2024
Drugmaker GSK says EU to review womb cancer treatment

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in
Oncology January 30,2024
Drugmaker GSK says EU to review womb cancer treatment

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in
Oncology January 30,2024
Researchers find new, safer treatment for serious side effect of bone marrow transplant

Researchers find new, safer treatment for serious side effect of bone marrow transplant

by The Mount Sinai HospitalHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaResear
Oncology January 30,2024
Researchers find new, safer treatment for serious side effect of bone marrow transplant

Researchers find new, safer treatment for serious side effect of bone marrow transplant

by The Mount Sinai HospitalHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/WikipediaResear
Oncology January 30,2024
Drug combo ups progression-free survival for metastatic prostate cancer

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord
Oncology January 30,2024
Drug combo ups progression-free survival for metastatic prostate cancer

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord
Oncology January 30,2024
Cancer cell repopulation after therapy: Study explores the mechanism

Cancer cell repopulation after therapy: Study explores the mechanism

by Impact Journals LLCPresumed models of tumor cell repopulation after escaping chemoradiation. Credit: 2023 Prakash and TelleriaThe past two decades have brought great progress in the treatment of ca
Oncology January 30,2024
Cancer cell repopulation after therapy: Study explores the mechanism

Cancer cell repopulation after therapy: Study explores the mechanism

by Impact Journals LLCPresumed models of tumor cell repopulation after escaping chemoradiation. Credit: 2023 Prakash and TelleriaThe past two decades have brought great progress in the treatment of ca
Oncology January 30,2024
Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainVitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31stEuropean
Oncology January 30,2024
Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainVitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31stEuropean
Oncology January 30,2024
Researchers develop liquid biopsy test for pediatric solid tumors

Researchers develop liquid biopsy test for pediatric solid tumors

by Children's Hospital Los AngelesCopy number alteration detection in liquid biopsies of pediatric solid tumor patients. Summary of copy number alteration (CNA) detection and disease status a
Oncology January 30,2024
Researchers develop liquid biopsy test for pediatric solid tumors

Researchers develop liquid biopsy test for pediatric solid tumors

by Children's Hospital Los AngelesCopy number alteration detection in liquid biopsies of pediatric solid tumor patients. Summary of copy number alteration (CNA) detection and disease status a
Oncology January 30,2024
Study: Mitochondria engage the integrated stress response to promote tumor growth

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot
Oncology January 30,2024
Study: Mitochondria engage the integrated stress response to promote tumor growth

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot
Oncology January 30,2024
Billions spent on cancer research but only small percentage goes to treatment, study shows

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204
Oncology January 30,2024
Billions spent on cancer research but only small percentage goes to treatment, study shows

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com